Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Sanara MedTech Inc. (NASDAQ: SMTI)
SMTI Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
195.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-18.90%
SMTI Stock Analysis
SMTI
PE Ratio:
379.8
SMTI
PEG Ratio:
1
SMTI
Forward EPS Growth (12 month):
373.50%
SMTI
PS Ratio:
1.8
SMTI
PSG Ratio:
0.1
SMTI
Forward Revenue Growth (12 month):
12.60%
SMTI Articles
No data was found